128 related articles for article (PubMed ID: 29071791)
21. Hepatitis C virus in chronic dialysis patients.
Natov SN; Pereira BJ
Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
[TBL] [Abstract][Full Text] [Related]
22. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
[TBL] [Abstract][Full Text] [Related]
23. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
24. Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
[TBL] [Abstract][Full Text] [Related]
25. Management of hepatitis C infection among patients with renal failure.
Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia.
Bosmans JL; Nouwen EJ; Behets G; Gorteman K; Huraib SO; Shaheen FA; Maertens G; Verpooten GA; Elseviers MM; de Broe ME
Clin Nephrol; 1997 Apr; 47(4):256-62. PubMed ID: 9128793
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence and genotype distribution changes in hepatitis C virus co-infection among human immunodeficiency virus-infected patients].
Cifuentes C; Mancebo-Hernández M; Pérez-Navarro E; Recio E; Monje-Agudo P; Valiente A; Pineda JA
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):110-2. PubMed ID: 25510595
[TBL] [Abstract][Full Text] [Related]
29. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
30. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
Jadoul M; Martin P
Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
[TBL] [Abstract][Full Text] [Related]
32. Hemodialysis access surgery--is there an increased risk of acquiring hepatitis C virus compared to other elective vascular interventions?
Assadian A; Assadian O; Holak G; Watkins-Riedel T; Senekowitsch C; Kovarik J; Hagmüller GW
Vasa; 2008 Feb; 37(1):81-5. PubMed ID: 18512545
[TBL] [Abstract][Full Text] [Related]
33. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.
Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S
Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hepatitis E virus infection in regular hemodialysis patients.
Kikuchi K; Yoshida T; Kimata N; Sato C; Akiba T
Ther Apher Dial; 2006 Apr; 10(2):193-7. PubMed ID: 16684223
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
37. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
38. Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy.
Li Cavoli G; Ferrantelli A; Bono L; Tortorici C; Giammarresi C; Zagarrigo C; Schillaci O; Tralongo A; Soresi M; Rotolo U
Int J Infect Dis; 2011 Aug; 15(8):e514-6. PubMed ID: 21680217
[TBL] [Abstract][Full Text] [Related]
39. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
Kojima A; Kakizaki S; Hosonuma K; Yamazaki Y; Horiguchi N; Sato K; Kitahara T; Mori M
J Gastroenterol Hepatol; 2013 Apr; 28(4):690-9. PubMed ID: 23302054
[TBL] [Abstract][Full Text] [Related]
40. [Prevention and treatment of hepatitis C infected patients on hemodialysis].
Resić H; Masnić F; Vukobrat-Bijedić Z; Kukavica N; Corić A; Bećiragić A; Ajanović S
Acta Med Croatica; 2012 Jul; 66(3):173-8. PubMed ID: 23441531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
